Human Phenotype Ontology 
Grandparent Node:
expand
Phenotypic abnormality (HP:0000118)help
Parent Node:
expand
Abnormality of metabolism/homeostasis (HP:0001939)help
..Starting node
..expand
Abnormal circulating nucleobase concentration (HP:0010932)help
Term ID: 10932
Name: Abnormal circulating nucleobase concentration
Synonym: Abnormal nucleoside levels
Definition: An abnormality of a nucleobase metabolic process.
Comments:
Reference: HP:0010932
Genes and Diseases:
 
       Child Nodes:
........expandIncreased phosphoribosylpyrophosphate synthetase (HP:0003240) help
........expandAbnormality of purine metabolism (HP:0004352) help
................... HP:0004368 Increased purine levels
................... HP:0004369 Decreased purine levels
................... HP:0010933 Abnormality of xanthine metabolism
................... HP:0011814 Increased urinary hypoxanthine
........expandAbnormality of pyrimidine metabolism (HP:0004353) help
................... HP:0003213 Deficient excision of UV-induced pyrimidine dimers in DNA
................... HP:0003267 Reduced orotidine 5-prime phosphate decarboxylase activity
................... HP:0003654 Reduced dihydropyrimidine dehydrogenase activity
................... HP:0010928 Abnormality of orotic acid metabolism
................... HP:0012127 Uraciluria

 Sister Nodes: 
..expandAbnormal blood ion concentration (HP:0003111) help
..expandAbnormal calcium-phosphate regulating hormone level (HP:0100530) help
..expandAbnormal cellular physiology (HP:0011017) help
..expandAbnormal circulating carbohydrate concentration (HP:0011013) help
..expandAbnormal circulating carboxylic acid concentration (HP:0004354) help
..expandAbnormal circulating lipid concentration (HP:0003119) help
..expandAbnormal circulating nitrogen compound concentration (HP:0004364) help
..expandAbnormal circulating porphyrin concentration (HP:0010472) help
..expandAbnormal circulating protein concentration (HP:0010876) help
..expandAbnormal circulating selenium concentration (HP:0031903) help
..expandAbnormal enzyme/coenzyme activity (HP:0012379) help
..expandAbnormal erythrocyte sedimentation rate (HP:0025021) help
..expandAbnormal homeostasis (HP:0012337) help
..expandAbnormal sweat homeostasis (HP:0040127) help
..expandAbnormality of acid-base homeostasis (HP:0004360) help
..expandAbnormality of fluid regulation (HP:0011032) help
..expandAbnormality of Krebs cycle metabolism (HP:0000816) help
..expandAbnormality of superoxide metabolism (HP:0004358) help
..expandAbnormality of temperature regulation (HP:0004370) help
..expandAbnormality of urine homeostasis (HP:0003110) help
..expandAbnormality of vitamin metabolism (HP:0100508) help
..expandAmyloidosis (HP:0011034) help
..expandBloodstream infectious agent (HP:0031863) help
..expandFood intolerance (HP:0012537) help
..expandGangrene (HP:0100758) help
..expandHyperbilirubinemia (HP:0002904) help
..expandIncreased level of propylene glycol in blood (HP:0410069) help
..expandKetosis (HP:0001946) help
..expandMolybdenum cofactor deficiency (HP:0003570) help
..expandobsolete Abnormality of glycoprotein metabolism (HP:0004367) help
..expandPresence of xenobiotic (HP:0031838) help
..expandReduced 5-oxoprolinase level (HP:0040142) help
..expandReduced acetaldehyde dehydrogenase level (HP:0003533) help
..expandReduced glutathione synthetase level (HP:0003343) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0ACAT1 CL E G H3893ORPHA:134Beta-ketothiolase deficiency91
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0ALDOB CL E G H229417OMIM:229600Fructose intolerance, hereditary73
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0ALDOB CL E G H229417ORPHA:469Hereditary fructose intolerance73
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome404
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0ATP7B CL E G H540870OMIM:277900Wilson disease315
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0CLDN16 CL E G H106862037OMIM:248250Hypomagnesemia 3, renal58
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0CTNS CL E G H14972518ORPHA:411634Juvenile nephropathic cystinosis178
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0DPYS CL E G H18073013OMIM:222748Dihydropyrimidinuria44
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0EHHADH CL E G H19623247ORPHA:3337Primary Fanconi renotubular syndrome2
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0FBP1 CL E G H22033606ORPHA:348Fructose-1,6-bisphosphatase deficiency64
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0G6PC1 CL E G H25384056OMIM:232200Glycogen storage disease ia
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0GATM CL E G H26284175ORPHA:3337Primary Fanconi renotubular syndrome86
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0GPHN CL E G H1024315465OMIM:615501Molybdenum cofactor deficiency, complementation group C18
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HMGCL CL E G H31555005ORPHA:203-hydroxy-3-methylglutaric aciduria35
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HMGCL CL E G H31555005OMIM:2464503-Hydroxy-3-Methylglutaryl-Coa lyase deficiency35
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HNF1B CL E G H692811630ORPHA:93111HNF1B-related autosomal dominant tubulointerstitial kidney disease90
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HNF1B CL E G H692811630OMIM:137920Renal cysts and diabetes syndrome90
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HNF4A CL E G H31725024OMIM:616026Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young138
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HPRT1 CL E G H32515157OMIM:300323Gout, hprt-related76
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HPRT1 CL E G H32515157ORPHA:79233Hypoxanthine guanine phosphoribosyltransferase partial deficiency76
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HPRT1 CL E G H32515157ORPHA:510Lesch-Nyhan syndrome76
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0HPRT1 CL E G H32515157OMIM:300322Lesch-Nyhan syndrome76
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIII56
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIII77
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type II4
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0MOCS1 CL E G H43377190OMIM:252150Molybdenum cofactor deficiency, complementation group A96
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0MOCS2 CL E G H43387193OMIM:252160Molybdenum cofactor deficiency, complementation group B26
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0MUC1 CL E G H45827508OMIM:174000Tubulointerstitial kidney disease, autosomal dominant, 21
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0MYC CL E G H46097553ORPHA:543Burkitt lymphoma11
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0NDUFAF6 CL E G H13768228625ORPHA:3337Primary Fanconi renotubular syndrome39
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0OTC CL E G H50098512OMIM:311250Ornithine transcarbamylase deficiency, hyperammonemia due to369
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PFKM CL E G H52138877ORPHA:371Glycogen storage disease due to muscle phosphofructokinase deficiency64
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PFKM CL E G H52138877OMIM:232800Glycogen storage disease VII64
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PHKA2 CL E G H52568926OMIM:306000Glycogen storage disease ixa54
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PHKB CL E G H52578927OMIM:261750Glycogen storage disease ixb101
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency52
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PNP CL E G H48607892ORPHA:760Purine nucleoside phosphorylase deficiency52
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0POLG CL E G H54289179OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)464
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 342
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophy42
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PRPS1 CL E G H56319462ORPHA:1187Lethal ataxia with deafness and optic atrophy49
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PRPS1 CL E G H56319462ORPHA:411536Mild phosphoribosylpyrophosphate synthetase superactivity49
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PRPS1 CL E G H56319462OMIM:300661Phosphoribosylpyrophosphate synthetase superactivity49
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PRPS1 CL E G H56319462ORPHA:411543Severe phosphoribosylpyrophosphate synthetase superactivity49
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0PYGM CL E G H58379726OMIM:232600Glycogen storage disease V166
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0REN CL E G H59729958OMIM:613092Hyperuricemic nephropathy, familial juvenile, 225
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SARS2 CL E G H5493817697OMIM:613845Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome60
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SEC61A1 CL E G H2992718276OMIM:617056Tubulointerstitial kidney disease, autosomal dominant, 52
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SH2B1 CL E G H2597030417ORPHA:261222Distal 16p11.2 microdeletion syndrome
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemia56
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC22A12 CL E G H11608517989OMIM:220150Hypouricemia, renal, 156
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC2A2 CL E G H651411006OMIM:227810Fanconi-Bickel syndrome71
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemia57
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC2A9 CL E G H5660613446OMIM:612076Hypouricemia, renal, 257
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC34A1 CL E G H656911019ORPHA:3337Primary Fanconi renotubular syndrome47
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib110
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC37A4 CL E G H25424061OMIM:232220Glycogen storage disease ib110
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic110
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0TNFRSF11A CL E G H879211908ORPHA:2801Juvenile Paget disease72
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0TNFRSF11B CL E G H498211909ORPHA:2801Juvenile Paget disease44
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0TNFRSF11B CL E G H498211909OMIM:239000Paget disease of bone 5, juvenile-onset44
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0TYMP CL E G H18903148OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)138
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0UMOD CL E G H736912559OMIM:162000Hyperuricemic nephropathy, familial juvenile, 166
HP:0010932HP:0010932Abnormal circulating nucleobase concentration0XDH CL E G H749812805OMIM:278300Xanthinuria, type I79
HP:0010932HP:0002149Hyperuricemia1ACAT1 CL E G H3893ORPHA:134Beta-ketothiolase deficiencyHP:0040281 - Very frequent91
HP:0010932HP:0002149Hyperuricemia1ALDOB CL E G H229417OMIM:229600Fructose intolerance, hereditary.73
HP:0010932HP:0002149Hyperuricemia1ALDOB CL E G H229417ORPHA:469Hereditary fructose intoleranceHP:0040283 - Occasional73
HP:0010932HP:0002149Hyperuricemia1ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0010932HP:0003537Hypouricemia1ATP7B CL E G H540870OMIM:277900Wilson disease315
HP:0010932HP:0002149Hyperuricemia1CLDN16 CL E G H106862037OMIM:248250Hypomagnesemia 3, renal.58
HP:0010932HP:0003537Hypouricemia1CTNS CL E G H14972518ORPHA:411634Juvenile nephropathic cystinosisHP:0040283 - Occasional178
HP:0010932HP:0004353Abnormal circulating pyrimidine concentration1DPYS CL E G H18073013OMIM:222748Dihydropyrimidinuria44
HP:0010932HP:0003537Hypouricemia1EHHADH CL E G H19623247ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent2
HP:0010932HP:0002149Hyperuricemia1FBP1 CL E G H22033606ORPHA:348Fructose-1,6-bisphosphatase deficiencyHP:0040282 - Frequent64
HP:0010932HP:0002149Hyperuricemia1G6PC1 CL E G H25384056OMIM:232200Glycogen storage disease ia.
HP:0010932HP:0003537Hypouricemia1GATM CL E G H26284175ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent86
HP:0010932HP:0003537Hypouricemia1GPHN CL E G H1024315465OMIM:615501Molybdenum cofactor deficiency, complementation group C.18
HP:0010932HP:0002149Hyperuricemia1HMGCL CL E G H31555005ORPHA:203-hydroxy-3-methylglutaric aciduriaHP:0040282 - Frequent35
HP:0010932HP:0002149Hyperuricemia1HMGCL CL E G H31555005OMIM:2464503-Hydroxy-3-Methylglutaryl-Coa lyase deficiency.35
HP:0010932HP:0002149Hyperuricemia1HNF1B CL E G H692811630ORPHA:93111HNF1B-related autosomal dominant tubulointerstitial kidney diseaseHP:0040283 - Occasional90
HP:0010932HP:0002149Hyperuricemia1HNF1B CL E G H692811630OMIM:137920Renal cysts and diabetes syndrome90
HP:0010932HP:0003537Hypouricemia1HNF4A CL E G H31725024OMIM:616026Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young.138
HP:0010932HP:0002149Hyperuricemia1HPRT1 CL E G H32515157OMIM:300323Gout, hprt-related.76
HP:0010932HP:0002149Hyperuricemia1HPRT1 CL E G H32515157ORPHA:79233Hypoxanthine guanine phosphoribosyltransferase partial deficiencyHP:0040282 - Frequent76
HP:0010932HP:0002149Hyperuricemia1HPRT1 CL E G H32515157ORPHA:510Lesch-Nyhan syndromeHP:0040281 - Very frequent76
HP:0010932HP:0002149Hyperuricemia1HPRT1 CL E G H32515157OMIM:300322Lesch-Nyhan syndrome.76
HP:0010932HP:0002149Hyperuricemia1LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040284 - Very rare56
HP:0010932HP:0002149Hyperuricemia1MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040284 - Very rare77
HP:0010932HP:0003537Hypouricemia1MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type II.4
HP:0010932HP:0004352Abnormal circulating purine concentration1MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type II4
HP:0010932HP:0003537Hypouricemia1MOCS1 CL E G H43377190OMIM:252150Molybdenum cofactor deficiency, complementation group A.96
HP:0010932HP:0003537Hypouricemia1MOCS2 CL E G H43387193OMIM:252160Molybdenum cofactor deficiency, complementation group B.26
HP:0010932HP:0002149Hyperuricemia1MUC1 CL E G H45827508OMIM:174000Tubulointerstitial kidney disease, autosomal dominant, 2.1
HP:0010932HP:0002149Hyperuricemia1MYC CL E G H46097553ORPHA:543Burkitt lymphomaHP:0040282 - Frequent11
HP:0010932HP:0003537Hypouricemia1NDUFAF6 CL E G H13768228625ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent39
HP:0010932HP:0004353Abnormal circulating pyrimidine concentration1OTC CL E G H50098512OMIM:311250Ornithine transcarbamylase deficiency, hyperammonemia due to369
HP:0010932HP:0002149Hyperuricemia1PFKM CL E G H52138877ORPHA:371Glycogen storage disease due to muscle phosphofructokinase deficiencyHP:0040282 - Frequent64
HP:0010932HP:0002149Hyperuricemia1PFKM CL E G H52138877OMIM:232800Glycogen storage disease VII.64
HP:0010932HP:0002149Hyperuricemia1PHKA2 CL E G H52568926OMIM:306000Glycogen storage disease ixa54
HP:0010932HP:0002149Hyperuricemia1PHKB CL E G H52578927OMIM:261750Glycogen storage disease ixb101
HP:0010932HP:0004352Abnormal circulating purine concentration1PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency52
HP:0010932HP:0003537Hypouricemia1PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency52
HP:0010932HP:0003537Hypouricemia1PNP CL E G H48607892ORPHA:760Purine nucleoside phosphorylase deficiencyHP:0040282 - Frequent52
HP:0010932HP:0004353Abnormal circulating pyrimidine concentration1POLG CL E G H54289179OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)464
HP:0010932HP:0002149Hyperuricemia1PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 3.42
HP:0010932HP:0002149Hyperuricemia1PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophyHP:0040283 - Occasional42
HP:0010932HP:0003537Hypouricemia1PRPS1 CL E G H56319462ORPHA:1187Lethal ataxia with deafness and optic atrophyHP:0040282 - Frequent49
HP:0010932HP:0002149Hyperuricemia1PRPS1 CL E G H56319462ORPHA:411536Mild phosphoribosylpyrophosphate synthetase superactivityHP:0040281 - Very frequent49
HP:0010932HP:0002149Hyperuricemia1PRPS1 CL E G H56319462OMIM:300661Phosphoribosylpyrophosphate synthetase superactivity49
HP:0010932HP:0002149Hyperuricemia1PRPS1 CL E G H56319462ORPHA:411543Severe phosphoribosylpyrophosphate synthetase superactivityHP:0040281 - Very frequent49
HP:0010932HP:0002149Hyperuricemia1PYGM CL E G H58379726OMIM:232600Glycogen storage disease V166
HP:0010932HP:0002149Hyperuricemia1REN CL E G H59729958OMIM:613092Hyperuricemic nephropathy, familial juvenile, 2.25
HP:0010932HP:0002149Hyperuricemia1SARS2 CL E G H5493817697OMIM:613845Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome.60
HP:0010932HP:0002149Hyperuricemia1SEC61A1 CL E G H2992718276OMIM:617056Tubulointerstitial kidney disease, autosomal dominant, 5.2
HP:0010932HP:0002149Hyperuricemia1SH2B1 CL E G H2597030417ORPHA:261222Distal 16p11.2 microdeletion syndromeHP:0040282 - Frequent
HP:0010932HP:0003537Hypouricemia1SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemiaHP:0040280 - Obligate56
HP:0010932HP:0003537Hypouricemia1SLC22A12 CL E G H11608517989OMIM:220150Hypouricemia, renal, 1.56
HP:0010932HP:0003537Hypouricemia1SLC2A2 CL E G H651411006OMIM:227810Fanconi-Bickel syndrome.71
HP:0010932HP:0003537Hypouricemia1SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemiaHP:0040280 - Obligate57
HP:0010932HP:0003537Hypouricemia1SLC2A9 CL E G H5660613446OMIM:612076Hypouricemia, renal, 257
HP:0010932HP:0003537Hypouricemia1SLC34A1 CL E G H656911019ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent47
HP:0010932HP:0002149Hyperuricemia1SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040281 - Very frequent110
HP:0010932HP:0002149Hyperuricemia1SLC37A4 CL E G H25424061OMIM:232220Glycogen storage disease ib.110
HP:0010932HP:0002149Hyperuricemia1SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic.110
HP:0010932HP:0002149Hyperuricemia1TNFRSF11A CL E G H879211908ORPHA:2801Juvenile Paget diseaseHP:0040281 - Very frequent72
HP:0010932HP:0002149Hyperuricemia1TNFRSF11B CL E G H498211909ORPHA:2801Juvenile Paget diseaseHP:0040281 - Very frequent44
HP:0010932HP:0002149Hyperuricemia1TNFRSF11B CL E G H498211909OMIM:239000Paget disease of bone 5, juvenile-onset.44
HP:0010932HP:0004353Abnormal circulating pyrimidine concentration1TYMP CL E G H18903148OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)138
HP:0010932HP:0002149Hyperuricemia1UMOD CL E G H736912559OMIM:162000Hyperuricemic nephropathy, familial juvenile, 1.66
HP:0010932HP:0004352Abnormal circulating purine concentration1XDH CL E G H749812805OMIM:278300Xanthinuria, type I79
HP:0010932HP:0004369Decreased circulating purine concentration2 CL E G H
HP:0010932HP:0033139Elevated circulating uracil concentration2DPYS CL E G H18073013OMIM:222748Dihydropyrimidinuria44
HP:0010932HP:0004368Increased circulating purine concentration2MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type II4
HP:0010932HP:0033139Elevated circulating uracil concentration2OTC CL E G H50098512OMIM:311250Ornithine transcarbamylase deficiency, hyperammonemia due to369
HP:0010932HP:0004368Increased circulating purine concentration2PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency52
HP:0010932HP:0034276Elevated circulating thymidine concentration2POLG CL E G H54289179OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)464
HP:0010932HP:0034277Elevated circulating deoxyuridine concentration2POLG CL E G H54289179OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)464
HP:0010932HP:0034277Elevated circulating deoxyuridine concentration2TYMP CL E G H18903148OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)138
HP:0010932HP:0034276Elevated circulating thymidine concentration2TYMP CL E G H18903148OMIM:603041Mitochondrial DNA depletion syndrome 1 (mngie type)138
HP:0010932HP:0004368Increased circulating purine concentration2XDH CL E G H749812805OMIM:278300Xanthinuria, type I79
HP:0010932HP:0034333Increased circulating hypoxanthine concentration3MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type II4
HP:0010932HP:0010933Hyperxanthinemia3MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type II4
HP:0010932HP:0033340Increased circulating guanosine concentration3PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency52
HP:0010932HP:0033339Increased circulating inosine concentration3PNP CL E G H48607892OMIM:613179Immunodeficiency due to purine nucleoside phosphorylase deficiency52
HP:0010932HP:0010933Hyperxanthinemia3XDH CL E G H749812805OMIM:278300Xanthinuria, type I79


Genes (47) :ACAT1 ALDOB ALMS1 ATP7B CLDN16 CTNS DPYS EHHADH FBP1 G6PC1 GATM GPHN HMGCL HNF1B HNF4A HPRT1 LMAN1 MCFD2 MOCOS MOCS1 MOCS2 MUC1 MYC NDUFAF6 OTC PFKM PHKA2 PHKB PNP POLG PPARG PRPS1 PYGM REN SARS2 SEC61A1 SH2B1 SLC22A12 SLC2A2 SLC2A9 SLC34A1 SLC37A4 TNFRSF11A TNFRSF11B TYMP UMOD XDH

Diseases (57) :ORPHA:134 OMIM:229600 ORPHA:469 OMIM:203800 OMIM:277900 OMIM:248250 ORPHA:411634 OMIM:222748 ORPHA:3337 ORPHA:348 OMIM:232200 OMIM:615501 ORPHA:20 OMIM:246450 ORPHA:93111 OMIM:137920 OMIM:616026 OMIM:300323 ORPHA:79233 ORPHA:510 OMIM:300322 ORPHA:35909 OMIM:603592 OMIM:252150 OMIM:252160 OMIM:174000 ORPHA:543 OMIM:311250 ORPHA:371 OMIM:232800 OMIM:306000 OMIM:261750 OMIM:613179 ORPHA:760 OMIM:603041 OMIM:604367 ORPHA:79083 ORPHA:1187 ORPHA:411536 OMIM:300661 ORPHA:411543 OMIM:232600 OMIM:613092 OMIM:613845 OMIM:617056 ORPHA:261222 ORPHA:94088 OMIM:220150 OMIM:227810 OMIM:612076 ORPHA:79259 OMIM:232220 OMIM:232240 ORPHA:2801 OMIM:239000 OMIM:162000 OMIM:278300
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.